Cancer Family
Adnexal Neoplasm
CI-CAN-00000005Explore in graph →
Non-malignant777 active trials5 approved drugs94 evidence items
- NCIt
- C212119
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000005Explore in graph →
Clinical trials
3,522 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03763123 | A Phase 1b Study of Sevacizumab in Combination With Chemotherapy in Chinese Patients With Platinum-Resistant Recurrent Ovarian Cancer. | unknown | Phase 1 | 48 | Jiangsu Simcere Pharmaceutical Co., Ltd.INDUSTRY | 1 | Dec 4, 2018 | clinicaltrials |
| NCT03517332 | Circulating Tumor DNA Exposure in Peripheral Blood | unknown | — | 10,000 | Quantgene Inc.INDUSTRY | 2 | Nov 20, 2018 | clinicaltrials |
| NCT03742388 | A Genomic Analysis of Evolution of Epithelia Ovarian Tumors | unknown | — | 40 | Lei LiOTHER | 1 | Nov 15, 2018 | clinicaltrials |
| NCT03742856 | A Multi-omics Study of Epithelial Ovarian Cancer | unknown | — | 80 | Lei LiOTHER | 1 | Nov 15, 2018 | clinicaltrials |
| NCT03291262 | Survival Outcomes of Ovarian Malignancies in Chinese Population | unknown | — | 5,000 | Lei LiOTHER | 1 | Nov 14, 2018 | clinicaltrials |
| NCT03388996 | Pelvic Microbiomes of Benign and Malignant Ovarian Diseases(MTBOD-1) | unknown | — | 40 | Lei LiOTHER | 1 | Nov 14, 2018 | clinicaltrials |
| NCT03738319 | Non-coding RNA in the Exosome of the Epithelia Ovarian Cancer | unknown | — | 160 | Lei LiOTHER | 1 | Nov 14, 2018 | clinicaltrials |
| NCT03740464 | Long-acting G-CSF for Febrile Neutropenia | unknown | Phase 3 | 556 | Lei LiOTHER | 1 | Nov 14, 2018 | clinicaltrials |
| NCT02480790 | Venous Thromboembolic Complications in Ovarian Cancer | unknown | — | 98 | Ole Thorlacius-Ussing, MD, DMSc, Professor of SurgeryOTHER | 1 | Oct 5, 2018 | clinicaltrials |
| NCT02981901 | Optimisation of Disease Management in Patients With Epithelial Ovarian Cancer in France(Ovaire01) | unknown | — | 376 | Centre Leon BerardOTHER | 1 | Aug 23, 2018 | clinicaltrials |
| NCT02681432 | Hyperthermic Intraperitoneal Chemotherapy With Paclitaxel in Advanced Ovarian Cancer(hipecova) | unknown | Phase 3 | 60 | PEDRO VILLAREJO CAMPOSOTHER | 1 | Aug 21, 2018 | clinicaltrials |
| NCT03618706 | Standard of Care Therapy With Involved Field Radiation Therapy for Selective Recurrent Ovarian Cancer | unknown | Phase 2 | 107 | Yonsei UniversityOTHER | 1 | Aug 7, 2018 | clinicaltrials |
| NCT03611179 | Upfront Treatment With Chemotherapy and Bevacizumab in Advanced Ovarian Cancer | unknown | Phase 2 | 40 | Nada Hassan SalahOTHER | 0 | Aug 2, 2018 | clinicaltrials |
| NCT02687321 | The Role of HE4 in the Follow-up of Advanced Ovarian, Fallopian Tube and Primary Peritoneal Cancer | unknown | — | 150 | Brno University HospitalOTHER | 6 | Jul 26, 2018 | clinicaltrials |
| NCT03283943 | PDL-1 Inhibition and Focal Sensitizing Radiotherapy in Recurrent Ovarian/Primary Peritoneal/Fallopian Tube Cancers. | unknown | Phase 1 | 22 | British Columbia Cancer AgencyOTHER | 1 | Jul 11, 2018 | clinicaltrials |
| NCT03547375 | Clinical Study of Apatinib in the Treatment of Advanced Ovarian Cancer After the Failure of Standard Chemotherapy | unknown | Phase 2 | 69 | Anhui Provincial HospitalOTHER_GOV | 0 | Jun 6, 2018 | clinicaltrials |
| NCT03539328 | Study on MK-3475 Plus Chemotherapy Versus Chemotherapy Alone in Recurrent, Platinum-resistant Ovarian Cancer(MITO27) | unknown | Phase 2 | 138 | Fondazione IRCCS Istituto Nazionale dei Tumori, MilanoOTHER | 1 | May 29, 2018 | clinicaltrials |
| NCT03399344 | Clinical Impact of Dedicated MR Staging of Ovarian Cancer(MRStagingOC) | unknown | N/A | 270 | The Netherlands Cancer InstituteOTHER | 1 | May 22, 2018 | clinicaltrials |
| NCT03526809 | Molecular Imaging and Spectroscopy With Stable Isotopes in Oncology and Neurology(MISSION-ovary) | unknown | — | 40 | Cambridge University Hospitals NHS Foundation TrustOTHER | 1 | May 16, 2018 | clinicaltrials |
| NCT03188159 | Vinorelbine in Relapsed Platinum Resistant or Refractory C5 High Grade Serous, Endometrioid, or Undifferentiated Primary Peritoneum, Fallopian Tube or Ovarian Cancer | unknown | Phase 2 | 36 | National University Hospital, SingaporeOTHER | 2 | Mar 29, 2018 | clinicaltrials |
| NCT01650376 | Phase Ib Study of Olaparib Plus Weekly Carboplatin and Paclitaxel in Relapsed Ovarian Cancer | unknown | Phase 1 / Phase 2 | 52 | Swedish Medical CenterOTHER | 1 | Mar 23, 2018 | clinicaltrials |
| NCT03076372 | A Study Evaluating MM-310 in Patients With Solid Tumors | unknown | Phase 1 | 34 | Merrimack PharmaceuticalsINDUSTRY | 1 | Feb 27, 2018 | clinicaltrials |
| NCT03446495 | An Observational Study of Combination of Pegylated Liposomal Doxorubicin and Trabectedin in Routine Practice in Patients With Recurrent Partial-platinum Sensitive Ovarian Cancer(Renaissance) | unknown | — | 60 | Suriya YessentayevaOTHER | 1 | Feb 26, 2018 | clinicaltrials |
| NCT00719303 | Diet and Physical Activity Change or Usual Care in Improving Progression-Free Survival in Patients With Previously Treated Stage II, III, or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer | unknown | Phase 3 | 1,070 | Gynecologic Oncology GroupNETWORK | 1 | Feb 19, 2018 | clinicaltrials |
| NCT02534922 | Study of Prolanta™ in Recurrent or Persistent Epithelial Ovarian Cancer(ProlantaOC) | unknown | Phase 1 | 18 | Oncolix, Inc.INDUSTRY | 1 | Feb 14, 2018 | clinicaltrials |
| NCT02178462 | Biomarkers for Gynecologic Cancer | unknown | — | 153 | Ajinomoto Co., Inc.INDUSTRY | 1 | Jan 31, 2018 | clinicaltrials |
| NCT03180177 | Efficacy of HIPEC as NACT and Postoperative Chemotherapy in the Treatment of Advanced-Stage Epithelial Ovarian Cancer(EHNPCTASEOC) | unknown | Phase 3 | 263 | Shu-Zhong CuiOTHER | 1 | Jan 24, 2018 | clinicaltrials |
| NCT03219242 | Primary Debulking Surgery Including Bowel Resection in Advanced Stage Ovarian Cancer Using Caiman® Technology(CAIMAN) | unknown | N/A | 40 | Catholic University of the Sacred HeartOTHER | 1 | Jan 16, 2018 | clinicaltrials |
| NCT03393507 | A Study of Apatinib Treatment in for Advanced Ovarian Cancer | unknown | Phase 2 | 34 | The People's Hospital of LeshanOTHER | 1 | Jan 16, 2018 | clinicaltrials |
| NCT02328716 | Cytoreduction With or Without Intraoperative Intraperitoneal Hyperthermic Chemotherapy (HIPEC) in Patients With Peritoneal Carcinomatosis From Ovarian Cancer, Fallopian Tube or Primary Peritoneal Carcinoma(CARCINOHIPEC) | unknown | Phase 3 | 32 | Fundacion para la Formacion e Investigacion Sanitarias de la Region de MurciaOTHER | 1 | Dec 13, 2017 | clinicaltrials |
| NCT03335241 | Study of Fludarabine With Pegylated Liposomal Doxorubicin Versus Pegylated Liposomal Doxorubicin Alone In Patients With Platinum Resistant/Refractory Ovarian Cancer | unknown | Phase 2 | 140 | Sun Yat-sen UniversityOTHER | 1 | Nov 13, 2017 | clinicaltrials |
| NCT03298074 | Apatinib Plus Etoposide Versus Etoposide Alone for Platinum-resistant Recurrent Ovarian Cancer | unknown | Phase 2 | 60 | Yang ZhijunOTHER | 0 | Sep 29, 2017 | clinicaltrials |
| NCT03235648 | Evaluation of Surgical Excision of Cardiophrenic Lymph Nodes in Patients With Advanced Ovarian Cancer | unknown | N/A | 25 | Mansoura UniversityOTHER | 1 | Aug 1, 2017 | clinicaltrials |
| NCT01738789 | EURAD-MR Classification : European Multicenter Study(EURAD) | unknown | — | 1,340 | Société d'Imagerie de la FemmeOTHER | 8 | Jul 26, 2017 | clinicaltrials |
| NCT02684318 | Study to Evaluate PM01183 in Combination With Olaparib in Advanced Solid Tumors | unknown | Phase 1 / Phase 2 | 100 | Poveda, Andrés, M.D.INDIV | 1 | Jun 22, 2017 | clinicaltrials |
| NCT01680575 | Study on Neutropenia Induced by Adjuvant Paclitaxel/Carboplatin Chemotherapy in Patients With Epithelial Ovarian Cancer | unknown | — | 750 | Asan Medical CenterOTHER | 1 | May 31, 2017 | clinicaltrials |
| NCT03019315 | The Analyses of Treatment Efficacy and Cost-effectiveness in Early-staged Ovarian Cancer Patients | unknown | — | 5,000 | National Taiwan University HospitalOTHER | 1 | Jan 16, 2017 | clinicaltrials |
| NCT03006939 | Fluid Balance During Surgery for Ovarian Cancer | unknown | — | 60 | University Hospital, BonnOTHER | 1 | Dec 30, 2016 | clinicaltrials |
| NCT02970786 | Phase I Trial: 68Ga-NODAGA-E(c[RGDyK])2 Positron Emission Tomography for Imaging Angiogenesis in Primary and Metastatic Tumor Lesions in Humans | unknown | Phase 1 | 10 | Rigshospitalet, DenmarkOTHER | 1 | Nov 22, 2016 | clinicaltrials |
| NCT02952183 | Efficacy of Pelvic Autonomic Nerve Monitoring System (PAMS I) in Female Patients With Pelvic Tumors(FUSION V) | unknown | N/A | 30 | Seoul National University HospitalOTHER | 1 | Nov 2, 2016 | clinicaltrials |
| NCT01600573 | Pazopanib and Weekly Topotecan in Patients Recurrent Ovarian Cancer (TOPAZ) | unknown | Phase 1 / Phase 2 | 68 | JSehouliOTHER | 1 | Oct 11, 2016 | clinicaltrials |
| NCT01889615 | Dual PETOvac - Dual Time PET/CT in the Preoperative Assessment of Ovarian Cancer(Dual PETOvac) | unknown | — | 180 | Odense University HospitalOTHER | 1 | Oct 6, 2016 | clinicaltrials |
| NCT02244502 | Safety, Feasibility and Effect of TTFields (200 kHz) Concomitant With Weekly Paclitaxel in Recurrent Ovarian Carcinoma (INNOVATE) | unknown | Phase 1 / Phase 2 | 31 | NovoCure Ltd.INDUSTRY | 4 | Sep 21, 2016 | clinicaltrials |
| NCT02861872 | Intra-peritoneal Chemotherapy in Ovarian Cancer | unknown | — | 15 | Radboud University Medical CenterOTHER | 1 | Aug 10, 2016 | clinicaltrials |
| NCT02457650 | T Cell Receptor-transduced T Cells Targeting NY-ESO-1 for Treatment of Patients With NY-ESO-1- Expressing Malignancies | unknown | Phase 1 | 36 | Shenzhen Second People's HospitalOTHER | 1 | Aug 3, 2016 | clinicaltrials |
| NCT02595021 | Total/Subtotal Colectomy in Ovarian Cancer | unknown | Phase 2 | 80 | Shanghai Gynecologic Oncology GroupOTHER_GOV | 1 | Jul 26, 2016 | clinicaltrials |
| NCT02545010 | Phase I Low Dose WART in Combination With Weekly Paclitaxel for Platinum Resistant Ovarian Cancer | unknown | Phase 1 | 24 | National University Hospital, SingaporeOTHER | 1 | Jun 22, 2016 | clinicaltrials |
| NCT02809339 | Improving Quality of Care for Patients With Recurrent Ovarian Cancer | unknown | — | 360 | Radboud University Medical CenterOTHER | 0 | Jun 22, 2016 | clinicaltrials |
| NCT02225015 | Cancer Prevention in Women With a BRCA Mutation | unknown | Phase 1 | 300 | Women's College HospitalOTHER | 1 | Jun 9, 2016 | clinicaltrials |
| NCT02638402 | Expression of Altered Glycosyltransferases, Mucins, and RTKs in Human Ovarian and Endometrial Cancers | unknown | — | 250 | National Taiwan University HospitalOTHER | 0 | May 13, 2016 | clinicaltrials |
Data updated 23 days agoSource updated Dec 4, 2018source: clinicaltrials